Nk-1 receptor antagonists for the treatment of neuronal...

Details Nk-1 receptor antagonists for the treatment of neuronal... Nk-1 receptor antagonists for the treatment of neuronal...

A - Human Necessities

61

K

A61K 31/445 (2006.01) A61K 31/135 (2006.01) A61K 31/136 (2006.01) A61K 31/137 (2006.01) A61K 31/33 (2006.01) A61K 31/40 (2006.01) A61K 31/438 (2006.01) A61K 31/439 (2006.01) A61K 31/451 (2006.01) A61K 31/4535 (2006.01) A61K 31/454 (2006.01) A61K 31/46 (2006.01) A61K 31/55 (2006.01) A61K 31/675 (2006.01)

Patent

CA 2164804

The present invention relates to a method of treating or preventing a disorder selected from stroke, epilepsy, head trauma, spinal cord trauma, ischemic neuronal damage such as cerebral ischemic damage from stroke or vascular occlusion (e.g., during open heart surgery), excitotoxic neuronal damage (e.g., in stroke or epilepsy) and amyotrophic lateral sclerosis in mammals, including humans, using an NK-1 antagonist. It also relates to a method of treating or preventing such disorders in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, pyrrolidine derivatives, azanorbornane derivatives, ethylene diamine derivatives and related compounds that are substance P receptor antagonists.

Affiliated with

Also associated with

Rating

Nk-1 receptor antagonists for the treatment of neuronal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nk-1 receptor antagonists for the treatment of neuronal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nk-1 receptor antagonists for the treatment of neuronal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1974874